Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-12

Clinical Trial Update: Blood Brain Barrier Opening in Alzheimer' Disease [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial exploring blood-brain barrier opening in Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Alzheimer Disease | Phase 1, Phase 2 | Status: COMPLETED